Harvard Management CO Inc Magenta Therapeutics, Inc. Transaction History

Harvard Management CO Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 10, 2019	SELL	$5.7 - $19.7 $448,983 - $1.55 Million	-78,769 Reduced 19.15%	332,610 $5.48 Million
Q4 2018 Feb 08, 2019	BUY	$5.57 - $11.65 $438,743 - $917,658	78,769 Added 23.68%	411,379 $2.35 Million
Q2 2018 Aug 10, 2018	BUY	$13.5 - $14.52 $4.49 Million - $4.83 Million	332,610 New	332,610 $4.49 Million

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Harvard Management CO Inc, based on Form 13F filings with the SEC.

Stay updated on Harvard Management CO Inc with notifications on news.